Established Clinician Investigator Award to Support Mentoring (KS1)

The Established Clinician Investigator Award to Support Mentoring, opportunity number PA-28-049, is a forecasted federal discretionary grant opportunity from the U.S. Department of Health and Human Services through the National Institutes of Health. The opportunity is associated with Assistance Listing 93.113, Environmental Health, and its stated category of funding activity is Health. The forecast was dated August 13, 2026 and was last updated on August 13, 2026. The opportunity is identified as a Grants Notice and is expected to support awards in fiscal year 2028. The purpose of the Established Clinician Investigator Award to Support Mentoring is to provide support to established clinician investigators for a sustained period of protected time so they can provide high-quality mentoring to early-career clinician research scientists. The source does not provide additional program objectives, specific research topics, allowable cost categories, spending restrictions, indirect cost limitations, subaward limitations, or a stated period of performance. The forecast also does not provide an estimated total program funding amount, award ceiling, award floor, or expected number of awards. The opportunity does not require cost sharing or matching. Eligible applicants include state governments, county governments, city or township governments, special district governments, independent school districts, public housing authorities and Indian housing authorities, federally recognized Native American tribal governments, Native American tribal organizations other than federally recognized tribal governments, public and state controlled institutions of higher education, private institutions of higher education, nonprofits with or without 501(c)(3) status other than institutions of higher education, small businesses, and for-profit organizations other than small businesses. The additional eligibility information also identifies faith-based or community-based organizations, eligible agencies of the federal government, and U.S. territories or possessions as eligible applicants. Foreign organizations are not eligible to apply. Non-U.S. components of U.S. organizations are also not eligible to apply. However, foreign components, as defined in the NIH Grants Policy Statement, are allowed. No state-specific or sub-state geographic restriction is identified for otherwise eligible U.S. applicants, so the opportunity is treated as nationwide for U.S. eligibility. The forecast does not state additional organizational capacity, size, experience, or track-record requirements beyond the applicant categories and foreign-organization limitations provided. The opportunity remains in the forecast stage rather than currently accepting applications. The estimated posting date is July 13, 2027, which is treated as the anticipated application opening date based on the information currently available. The estimated application due date is October 12, 2027. No letter of intent, concept paper, pre-proposal, notice of intent, initial application, or other pre-application gating requirement is stated in the provided forecast. The source also does not identify application forms, required uploads, narrative questions, submission steps beyond the Grants.gov opportunity context, evaluation criteria, review priorities, or other application components. The estimated award date is July 1, 2028, and the estimated project start date is July 1, 2028. The forecast does not state that the opportunity is rolling or that it recurs annually, biennially, quarterly, or on another recurring schedule, so no future recurring cycle is inferred. For questions, the listed contact is the Division of Biomedical Research Workforce, which directs applicants to contact the program by email at NIHTrain@mail.nih.gov. No individual grantor contact name or telephone number is provided in the source.